Science Explorer Back to mapMap
Discussion
Researcher · Genecast (China) · China

Li‐Di Xu

Li‐Di Xu publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research and RNA modifications and cancer.

ORCID 0000-0002-3780-4972 OpenAlex
World rank
#3,254,311
of 7,710,434 ranked researchers
Rank in China
#511,366
of 978,568
Works
28
Citations
424
Citations per work
15.1
h-index
7
i10-index 6Top 91% in Molecular Biology
Li‐Di Xu

What does Li‐Di Xu research?

Li‐Di Xu's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (45%), Immunology and Microbiology (2%).

Life Sciences: 13 works · 47.5% of their workBiochemistry, Genetics and Molecular Biology: 13 works · 45.0% of their workMolecular Biology: 8 works · 30.0% of their workCancer Research: 4 works · 15.0% of their workImmunology and Microbiology: 1 works · 2.5% of their workImmunology: 1 works · 2.5% of their workHealth Sciences: 13 works · 45.1% of their workMedicine: 13 works · 45.1% of their workPulmonary and Respiratory Medicine: 8 works · 28.8% of their workOncology: 5 works · 16.3% of their workEverything else: 1 works · 4.9% of their workSocial Sciences: 1 works · 2.5% of their workSocial Sciences: 1 works · 2.5% of their workSociology and Political Science: 1 works · 2.5% of their workTHEIR WORKLi‐Di Xu28works
Life Sciences48%Health Sciences45%Social Sciences2%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1345.0%
    2. Immunology and Microbiology12.5%
    1. Medicine1345.1%
  3. Everything else14.9%
    1. Social Sciences12.5%
  1. 1Molecular Biology30% of their works
  2. 2Pulmonary and Respiratory Medicine29% of their works
  3. 3Oncology16% of their works
  4. 4Cancer Research15% of their works
  5. 5Immunology2% of their works
  6. 6Sociology and Political Science2% of their works

Research topics

Which keywords describe Li‐Di Xu's research?

The keywords of their largest research topics: Targeted Therapy, Genomic Profiling, Prostate Cancer, Cancer Genomics, Immunotherapy, Mutational Signatures, Androgen Receptor and Hormone Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy152 topics
  2. Genomic Profiling112 topics
  3. Prostate Cancer112 topics
  4. Cancer Genomics101 topic
  5. Immunotherapy102 topics
  6. Mutational Signatures101 topic
  7. Androgen Receptor61 topic
  8. Hormone Therapy61 topic
  9. ALK Inhibitors51 topic
  10. EGFR Mutations51 topic
  11. RNA methylation51 topic
  12. Radiation Therapy51 topic
  13. Screening51 topic
  14. m6A-seq51 topic
  15. Alternative Splicing41 topic
  16. Pancreatic Cancer41 topic
  17. RNA-Binding Proteins41 topic
  18. Surgical Complications41 topic
  19. ADAR Deaminases31 topic
  20. RNA Editing31 topic

Where does Li‐Di Xu work?

Li‐Di Xu's main affiliation in the publication record is Genecast (China), China.

How many publications and citations does Li‐Di Xu have?

OpenAlex counts 28 works and 424 citations for Li‐Di Xu, an h-index of 7, ranking #3,254,311 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Li‐Di Xu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.